Healthy volunteers help test new Drug's safety
NCT ID NCT06007638
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 33 times
Summary
This early-stage study tested a new drug called LY3876602 in 74 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo, and researchers measured drug levels in blood and spinal fluid. No treatment was given for any disease; the goal was simply to gather safety and dosing information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON Early Phase Services, LLC
Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.